Breast reconstruction surgery means meticulous craftsmanship by experienced surgeons
Reconstructing a removed breast is part of the treatment path of many breast cancer patients. The goal of the surgery...
Read moreMon–Thu 8–18, Fri 8–16
At Docrates Cancer Center magnetic resonance imaging is offered to give information about the extent and the spread of gynaecological cancer. Imaging is also used when planning individual cancer care. Our imaging specialists and our newest three-tesla scanner enables more specific diagnosis and more tailored treatment plans. Docrates Cancer Center offers quick access to state-of-the art imaging equipment.
Magnetic resonance imaging can be utilized within cancer diagnostics and also in follow-up of cancer treatment results and if local reocurrance is suspected. Then magnetic resonance imaging is complementing other imaging or can verify local and spread metastases.
Magnetic resonance imaging can be used in many gynaecological areas due to its good detection of different soft tissues. With magnetic resonance imaging it is possible to detect deviant tissues for example in cervical and uterus cancer and also in cancer in vagina and genitals. With magnetic resonance imaging of ovaries for example benign changes from malign ones can be spotted. Also more precise timing of contrast agent is aiming at more exact definition of abnormal changes.
Magnetic resonance imaging is especially used in benign changes in endometeriosis as the deep metastases may be detected only with magnetic resonance imaging.
At Docrates Cancer Center we have expertise within imaging treatments of gynaecological cancers. Our radiology specialist Johanna Virtanen is an expert of gynaecological cancer imaging among others.
At Docrates, MRI scans are performed using the newest three-tesla scanner by Siemens, Magnetom Vida 3T. It produces scans using a three-tesla magnetic field. This enables us to make even more specific diagnoses, and as a result, create better and more individually tailored treatment plans.
Reconstructing a removed breast is part of the treatment path of many breast cancer patients. The goal of the surgery...
Read moreNew forms of treatment based on molecular diagnostics enable more and more patients to completely recover from cancer, and make...
With a transaction signed on 2 September 2024, Mehiläinen has acquired Docrates Ltd, as a result of which Docrates Cancer...
On 27, August 2024, the Finnish Competition and Consumer Authority (FCCA) approved the merger of Mehiläinen and Docrates Cancer Center....
Contact us!
Mon-Thu 8:00-18:00, Fri 8:00-16:00